onr:"swepub:oai:DiVA.org:uu-127469"
Search: onr:"swepub:oai:DiVA.org:uu-127469" > Engineering and cha...
- 1 of 1
- Previous record
- Next record
- To hitlist
Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule
-
- Friedman, Mikaela (author)
- KTH,Molekylär Bioteknologi
-
- Lindström, Sara (author)
- KTH,Nanobioteknologi
-
- Ekerljung, Lina (author)
- Uppsala universitet,Enheten för biomedicinsk strålningsvetenskap
- show more...
- show less...
- (creator_code:org_t)
- 2009
- 2009
- English.
- In: Biotechnology and applied biochemistry. - 0885-4513 .- 1470-8744. ; 54, s. 121-131
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- HER2 (human epidermal-growth-factor receptor-2; ErbB2) and EGFR (epidermal-growth-factor receptor) are overexpressed in various forms of cancer, and the co-expression of both HER2 and EGFR has been reported in a number of studies. The simultaneous targeting of HER2 and EGFR has been discussed as a strategy with which to potentially increase efficiency and selectivity in molecular imaging and therapy of certain cancers. In an effort to generate a molecule capable of bispecifically targeting HER2 and EGFR, a gene fragment encoding a bivalent HER2-binding affibody molecule was genetically fused in-frame with a bivalent EGFR-binding affibody molecule via a (G(4)S)(3) [(Gly(4)-Ser)(3)]-encoding gene fragment. The encoded 30 kDa affibody construct (Z(HER2))(2)-(G(4)S)(3)-(Z(EGFR))(2), with potential for bs (bispecific) binding to HER2 and EGFR, was expressed in Escherichia coli and characterized in terms of its binding capabilities. The retained ability to bind HER2 and EGFR separately was demonstrated using both biosensor technology and flow-cytometric analysis, the latter using HER2- and EGFR-overexpressing cells. Furthermore, simultaneous binding to HER2 and EGFR was demonstrated in: (i) a sandwich format employing real-time biospecific interaction analysis where the bs affibody molecule bound immobilized EGFR and soluble HER2; (ii) immunofluorescence microscopy, where the bs affibody molecule bound EGFR-overexpressing cells and soluble HER2; and (iii) a cell-cell interaction analysis where the bs affibody molecule bound HER2-overexpressing SKBR-3 cells and EGFR-overexpressing A-431 cells. This is, to our knowledge, the first reported bs affinity protein with potential ability for the simultaneous targeting of HER2 and EGFR. The potential future use of this and similar constructs, capable of bs targeting of receptors to increase the efficacy and selectivity in imaging and therapy, is discussed.
Subject headings
- TEKNIK OCH TEKNOLOGIER -- Industriell bioteknik (hsv//swe)
- ENGINEERING AND TECHNOLOGY -- Industrial Biotechnology (hsv//eng)
Keyword
- bispecifc (bs) affibody molecule
- human epidermal-growth-factor receptor-3 (ErbB)
- microwell array
- protein engineering
- tumour targeting
- MEDICINE
- MEDICIN
- Bioengineering
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Biotechnology and applied biochemistry (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Friedman, Mikael ...
- Lindström, Sara
- Ekerljung, Lina
- Andersson-Svahn, ...
- Carlsson, Jörgen
- Brismar, Hjalmar
- show more...
- Gedda, Lars
- Frejd, Fredrik Y ...
- Ståhl, Stefan
- show less...
- About the subject
-
- ENGINEERING AND TECHNOLOGY
- ENGINEERING AND ...
- and Industrial Biote ...
- Articles in the publication
- Biotechnology an ...
- By the university
- Uppsala University
- Royal Institute of Technology
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
